PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.116199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Gurpreet K Arora und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Metabolism and Microenvironment Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Iron, Glucose, Phosphotransferases (Alcohol Group Acceptor). Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Phosphoinositide kinases generate distinct phosphoinositides that regulate pathways to support tumorigenesis. Phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) have garnered interest for their role in cancer metabolism; however, their function in pancreatic ductal adenocarcinoma (PDAC) remains unexplored. We identify PI5P4Kα as a critical dependency to support the unique metabolic demands of PDAC cells through its key role in the acquisition of essential metabolic substrates, including glucose and iron. Our data show that inhibition of PI5P4Kα creates a metabolic bottleneck that PDAC cells cannot overcome through adaptive shifts, leading to cancer-specific apoptotic cell death that is reversible by iron supplementation. Notably, we find that PI5P4Kα knockdown suppresses tumor growth in a xenograft mouse model of PDAC. These results not only illuminate the mechanistic underpinnings of PI5P4Kα function in PDAC but also position it as a promising therapeutic target for this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Metabolism and Microenvironment Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
- Department of Pathology and Molecular Pathology, University Hospital Zürich and the University of Zurich (UZH), 8006 Zurich, Switzerland.
- Cancer Metabolism Core, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
- Flow Cytometry Core, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
- Cancer Metabolism and Microenvironment Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. Electronic address: ccommisso@sbpdiscovery.org.
- Cancer Metabolism and Microenvironment Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. Electronic address: bemerling@sbpdiscovery.org.
Förderung
- NCI NIH HHS
- NIH HHS
- NIGMS NIH HHS
- NIH National Institute of General Medical Sciences
- National Cancer Institute
- American Cancer Society
- Basic Research Laboratory
- American Cyronics Society
Zitieren
APA
Arora, G. K., Loughran, R. M., Ly, K., Galapate, C. M., Llorente, A., Anderson, T. R., Zhang, C. Y., Grenier, S. F., Ling, L., Crabtree, S., Lambies, G., Pauli, C., Scott, D. A., Altman, Y., Portillo, B., Murad, R., Commisso, C., & Emerling, B. M. (2025). PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116199
Vancouver
Arora GK, Loughran RM, Ly K, Galapate CM, Llorente A, Anderson TR, et al. PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116199
BibTeX
@article{Arora2025,
author = {Arora, Gurpreet K and Loughran, Ryan M and Ly, Kyanh and Galapate, Cheska Marie and Llorente, Alicia and Anderson, Taylor R and Zhang, Cynthia Y and Grenier, Shea F and Ling, Li and Crabtree, Sophia and Lambies, Guillem and Pauli, Chantal and Scott, David A and Altman, Yoav and Portillo, Benji and Murad, Rabi and Commisso, Cosimo and Emerling, Brooke M},
title = {PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.116199}
}
EUVIMED